Gene · 429
Papers4,495
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 4,495
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcription factor-based direct conversion of human fibroblasts to functional astrocytes. | Stem Cell Reports | 2022 | 35750047 | PubTator, text mining | PubMed |
| Inhibition of Karyopherin β1-Mediated Nuclear Import Disrupts Oncogenic Lineage-Defining Transcription Factor Activity in Small Cell Lung Cancer. | Cancer Res | 2022 | 35748745 | PubTator, text mining | PubMed |
| Generation of functional human oligodendrocytes from dermal fibroblasts by direct lineage conversion. | Development | 2022 | 35748297 | PubTator, text mining | PubMed |
| [Clinical Progress in the Immunotherapy of Small Cell Lung Cancer]. | Zhongguo Fei Ai Za Zhi | 2022 | 35747922 | PubTator, text mining | PubMed |
| Bromodomain and Extra-Terminal Protein Inhibitors: Biologic Insights and Therapeutic Potential in Pediatric Brain Tumors. | Pharmaceuticals (Basel) | 2022 | 35745584 | PubTator, text mining | PubMed |
| Serum-Free Cultures: Could They Be a Future Direction to Improve Neuronal Differentiation of Mesenchymal Stromal Cells? | Int J Mol Sci | 2022 | 35742836 | PubTator, text mining | PubMed |
| The Intricate Epigenetic and Transcriptional Alterations in Pediatric High-Grade Gliomas: Targeting the Crosstalk as the Oncogenic Achilles' Heel. | Biomedicines | 2022 | 35740334 | PubTator, text mining | PubMed |
| Functional regulations between genetic alteration-driven genes and drug target genes acting as prognostic biomarkers in breast cancer. | Sci Rep | 2022 | 35739271 | PubTator, text mining | PubMed |
| The Mechanism and Function of Glia in Parkinson's Disease. | Front Cell Neurosci | 2022 | 35722618 | PubTator, text mining | PubMed |
| A combined human gastruloid model of cardiogenesis and neurogenesis. | iScience | 2022 | 35721464 | PubTator, text mining | PubMed |
| Regenerative and restorative medicine for eye disease. | Nat Med | 2022 | 35715505 | PubTator, text mining | PubMed |
| An Isogenic Collection of Pluripotent Stem Cell Lines With Elevated α-Synuclein Expression Validated for Neural Induction and Cortical Neuron Differentiation. | Front Cell Dev Biol | 2022 | 35712660 | PubTator, text mining | PubMed |
| NRBF2 regulates the chemoresistance of small cell lung cancer by interacting with the P62 protein in the autophagy process. | iScience | 2022 | 35712081 | PubTator, text mining | PubMed |
| Modeling Brain Tumors: A Perspective Overview of in vivo and Organoid Models. | Front Mol Neurosci | 2022 | 35706426 | PubTator, text mining | PubMed |
| Signal pathways and precision therapy of small-cell lung cancer. | Signal Transduct Target Ther | 2022 | 35705538 | PubTator, text mining | PubMed |
Adipose tissue derived stromal cells in a gelatin-based 3D matrix with exclusive ascorbic acid signalling emerged as a novel neural tissue engineering construct: an innovative prototype for soft tissue. | Regen Biomater | 2022 | 35702348 | PubTator, text mining | PubMed |
| First-Line Treatment for Advanced SCLC: What Is Left Behind and Beyond Chemoimmunotherapy. | Front Med (Lausanne) | 2022 | 35692538 | PubTator, text mining | PubMed |
| Targeting Lysine-Specific Demethylase 1 Rescues Major Histocompatibility Complex Class I Antigen Presentation and Overcomes Programmed Death-Ligand 1 Blockade Resistance in SCLC. | J Thorac Oncol | 2022 | 35691495 | PubTator, text mining | PubMed |
| Expression of novel neuroendocrine markers in breast carcinomas: a study of INSM1, ASCL1, and POU2F3. | Hum Pathol | 2022 | 35690220 | PubTator, text mining | PubMed |
| Reading oscillatory instructions: How cells achieve time-dependent responses to oscillating transcription factors. | Curr Opin Cell Biol | 2022 | 35690043 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/429/papers?page=60